The Parker Foundation

The Wall Street Journal June 26, 2015

Sean Parker: Philanthropy for Hackers

Read Article | Download PDF

Filter By

Time FEBRUARY 26, 2024

An Asthma Drug Can Drastically Reduce Food Allergies
NPR FEBRUARY 26, 2024

Asthma drug can help reduce allergic reactions for those with severe food allergies
Stanford Medicine February 25, 2024

Drug limits dangerous reactions to allergy-triggering foods, Stanford Medicine-led study of kids finds
The New England Journal of Medicine February 25, 2024

Omalizumab for the Treatment of Multiple Food Allergies
U.S. Food & Drug Administration February 16, 2024

FDA Approves First Medication to Help Reduce Allergic Reactions to Multiple Foods After Accidental Exposure
NPR July 9, 2023

Young families continued to leave cities last year – but at a slower pace
CBS July 6, 2023

"Persistent poverty" exists across much of the U.S.: "The ultimate left-behind places"
AXIOS January 25, 2023

The pandemic surge in entrepreneurship is still going strong
STAT December 23, 2022

Parker Institute extends ‘crazy idea’ funding to two more cancer centers
New York Times December 5, 2022

‘Innovation Hubs’ Aim to Lift Distressed Areas. Congress Just Has to Fund Them.
The New York Times NOVEMBER 6, 2019

Crispr Takes Its First Steps in Editing Genes to Fight Cancer
TechCrunch OCTOBER 17, 2019

ArsenalBio emerges from stealth with $85 million and a dream team to fight cancer
Forbes OCTOBER 17, 2019

Sean Parker-Backed ArsenalBio Wants To Create Better Weapons Against Cancer
YAHOO! Finance SEPTEMBER 3, 2019

Ardigen Was Accepted Into the Prestigious TESLA Consortium Working to Improve Personalization of Immunotherapies
STAT News JULY 9, 2019

The Parker Institute looks to grow, leveraging outside donors and equity stakes
Obama Foundation JUNE 17, 2019

Obama Foundation Announces Addition of Sean Parker to the Board of Directors
dLife MAY 29, 2019

Parker Institute, JDRF And Helmsley Charitable Trust Form New Research Initiative
New York Times April 3, 2019

America’s Biggest Economic Challenge May Be Demographic Decline
BioSpace MARCH 20, 2019

Parker Institute to Share Pancreatic Cancer Trial Results, Microbiome and Immunotherapy Research, and New CAR-T Approaches at AACR 2019
Inside Philanthropy February 26, 2019

"A Lot Has Happened in Three Years." What’s Going on with the Parker Institute?

The Parker Foundation (en-US)

Essential Reading

Sean Parker: Philanthropy for Hackers

All News

An Asthma Drug Can Drastically Reduce Food Allergies

Asthma drug can help reduce allergic reactions for those with severe food allergies

Drug limits dangerous reactions to allergy-triggering foods, Stanford Medicine-led study of kids finds

Omalizumab for the Treatment of Multiple Food Allergies

FDA Approves First Medication to Help Reduce Allergic Reactions to Multiple Foods After Accidental Exposure

Young families continued to leave cities last year – but at a slower pace

"Persistent poverty" exists across much of the U.S.: "The ultimate left-behind places"

The pandemic surge in entrepreneurship is still going strong

Parker Institute extends ‘crazy idea’ funding to two more cancer centers

‘Innovation Hubs’ Aim to Lift Distressed Areas. Congress Just Has to Fund Them.

Crispr Takes Its First Steps in Editing Genes to Fight Cancer

ArsenalBio emerges from stealth with $85 million and a dream team to fight cancer

Sean Parker-Backed ArsenalBio Wants To Create Better Weapons Against Cancer

Ardigen Was Accepted Into the Prestigious TESLA Consortium Working to Improve Personalization of Immunotherapies

The Parker Institute looks to grow, leveraging outside donors and equity stakes

Obama Foundation Announces Addition of Sean Parker to the Board of Directors

Parker Institute, JDRF And Helmsley Charitable Trust Form New Research Initiative

America’s Biggest Economic Challenge May Be Demographic Decline

Parker Institute to Share Pancreatic Cancer Trial Results, Microbiome and Immunotherapy Research, and New CAR-T Approaches at AACR 2019

"A Lot Has Happened in Three Years." What’s Going on with the Parker Institute?